Bruker
产品与解决方案 应用 服务与支持 新闻和活动 关于我们 职业
请至少输入2个字符 (您当前输入的是1个字符) 。

Languages

Banner Image ADLM conference
Banner Image ADLM conference
July 26 - 30 | Anaheim, CA

ADLM 2026

Bringing Chromatography-Free to the Masses

Welcome to ADLM 2026

We are excited to invite you to the 2026 Annual Meeting of the Association for Diagnostics & Laboratory Medicine in Anaheim, CA. This year’s conference is set to be a remarkable event, gathering leading experts, researchers, and industry professionals from across the globe.

Bringing chromatography-free analysis to the masses, this solution enables high-throughput screening while offering a sustainable, user-friendly way to explore the future of quantitative analysis.

Connect with our specialists: Stop by our booth #1029 to connect with our experts, explore our workflows, and see how your lab can move faster without compromise. We are also hosting:

  • 1:1 meetings with our specialists
  • Lab Accelerator Program sessions to support your next step

We look forward to meeting you in Anaheim and to discussing how our innovative solutions can meet your analytical requirements.

 

We also invite you to follow us on LinkedIn for updates, insights, and what’s next in mass spectrometry.

Event Details

Bruker Booth #1029

July 26 - 30, 2026

Anaheim Convention Center, Anaheim, CA

Rapid toxicology screening for novel benzodiazepines and opioids by DART-MSMS
Joshua DeBord, Ph.D., Senior Scientist, Center for Forensic Science Research and Education, PA, USA

Scientific Session (34228 Alternative sampling for rapid toxicology screening by mass spectrometry)
Anaheim Convention Center | Room 210CD
Wednesday, July 29, 2026 from 2:30 pm - 4:00 pm

Rapid, Chromatography-Free Screening

High-throughput sample screening.

Sustainable, user-friendly, high-throughput screening saving time and costs while shaping the future of quantitative analysis.

 

Rapid chromatography-free screens and quantitation enabled by DART-MS: the EVOQ® DART-TQ+ is designed to deliver exceptional analytical performance day in, day out.

EVOQ® DART-TQ+ is the world’s first triple quadrupole MS system specifically designed for DART ion source plug-and-play operation, allowing seamless source parameters and automation control in routine laboratory environments.

您需要接受 cookie 才能播放该视频。

Accelerate today, Expand tomorrow.

Discover the EVOQ® DART-TQ+ featuring RECIPE's ClinMass Kits now and ClinDART just ahead

Learn more Download brochure

Boost your lab’s performance with a platform built for both established and next-gen workflows: implement proven LC-MS workflows today and be ready for chromatography-free DART-MS innovation tomorrow – only on the EVOQ® DART-TQ+.

 

Mass spectrometry offers highly sensitive, accurate, and precise analysis of complex samples, delivering performance beyond conventional analytical technologies. Bruker’s EVOQ® DART-TQ+ extends the power of triple quadrupole mass spectrometry to clinical research in a fast, robust, and user-friendly platform. Through a collaboration with RECIPE Chemical + Instruments GmbH, the system supports both the established ClinMass® LC-MS assay kits and future chromatography-free ClinDART™ assays, providing exceptional flexibility, efficiency, and throughput. Widely recognized as a gold standard in LC-MS-based clinical research, RECIPE’s ClinMass® kits deliver outstanding analytical specificity and reproducibility and are fully compatible with the EVOQ® DART-TQ+ when operated with the VIP-HESI source.

Further Resources

Interview

Bruker’s Investment in RECIPE Expands Access to Chromatography-Free MS

Bruker’s new partnership will accelerate mass spectrometry use in clinical diagnostics research and toxicology screening.
Read the article
App Note

Development of a Rapid DART-MS/MS Method for the Quantitation of Mycophenolic Acid (MPA) as a Research Study

This study demonstrates that DART-MS/MS has the potential to provide an chromatography-free approach for rapidly quantifying Mycophenolic Acid (MPA) in serum. A maximized throughput can be achieved with an analysis time of 26 sec/sample or 96 samples in less than 42 min.
Download App Note
App Note

Quantitation of neuroleptics in human serum/plasma by
LC-MS/MS for clinical research

Implementation of an analytical method for the simultaneous quantitation of neuroleptics in human serum/plasma on a Bruker EVOQ® DART-TQ+ triple quadrupole mass spectrometer for research purposes. Sample preparation involves protein precipitation using a proprietary reagent including isotopically labelled internal standards. Chromatographic separation was completed within 6 min, with detection performed on the Bruker EVOQ®  DART-TQ+ mass spectrometer in Multiple Reaction Monitoring (MRM) mode.
Download App Note
Press Release

Bruker Announces Majority Acquisition of RECIPE

Bruker and RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring, are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays.
Read Press release
App Note

Rapid Chromatography-Free Screening of Benzodiazepine Drugs and Metabolites

Analysis of urine-based benzodiazepine drugs and associated metabolites using the EVOQ® DART-TQ+ mass spectrometer with a Direct Analysis in Real Time (DART) ion source provides rapid and accurate quantitative confirmatory screening results in a chromatography-free workflow.
Download App Note
App note    

Quantitation of antidepressants in human serum/plasma by LC-MS/MS for clinical research

Implementation of an analytical method for the simultaneous quantification of 36 antidepressants in human serum/plasma on a Bruker EVOQ® DART-TQ+ triple quadrupole mass spectrometer for research purposes. Sample preparation involves protein precipitation using a proprietary reagent including isotopically labelled internal standards. Chromatographic separation was completed within 3.7 min, with detection performed on the Bruker EVOQ® DART-TQ+ mass spectrometer in Multiple Reaction Monitoring (MRM) mode. 
Read App Note
Interview

Bruker tackles drugs of abuse and POPs issues

Are you curious about the latest advancements in drug screening, sustainable analytical methods, and high-resolution screening? Jeffrey Zonderman talked to SelectScience® and shared insights on solutions for drugs of abuse screening and POPs analysis, greener and more efficient alternatives to chromatographic methods and untargeted High-Resolution screening.
Watch Interview

 

 

*仅供研究使用，不能用于临床诊断程序。